BamSEC and AlphaSense Join Forces
Learn More

Leap Therapeutics Inc.

NASDAQ: LPTX    
Share price (1/8/25): $3.38    
Market cap (1/8/25): $130 million

Indentures Filter

EX-4.1
from 8-K 15 pages Leap Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-Q 10 pages Flame Biosciences, Inc. Amended and Restated Stock Warrant
12/34/56
EX-4.1
from 8-K 14 pages Leap Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.20
from S-3/A 37 pages Indenture
12/34/56
EX-4.1
from 8-K 15 pages Leap Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 21 pages This Warrant and the Underlying Shares Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or Under the Securities Laws of Any State. These Securities May Not Be Offered, Sold or Otherwise Transferred, Pledged or Hypothecated Except (1) Pursuant to an Exemption From Registration Under the Securities Act or in a Transaction Not Subject to the Registration Requirements of the Securities Act or (2) Pursuant to an Effective Registration Statement Under the Securities Act, in Each Case, in Accordance With All Applicable State Securities Laws and in the Case of a Transaction Exempt From Registration, Unless the Company Has Received an Opinion of Counsel Reasonably Satisfactory to It That Such Transaction Does Not Require Registration Under the Securities Act and Such Other Applicable Laws. Leap Therapeutics, Inc. Warrant to Purchase Common Stock 1 Ntd: To Be Date That Is Seven Years From the Closing Date of the Main Transaction
12/34/56
EX-4.2
from 8-K 19 pages This Warrant and the Underlying Shares Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or Under the Securities Laws of Any State. These Securities May Not Be Offered, Sold or Otherwise Transferred, Pledged or Hypothecated Except (1) Pursuant to an Exemption From Registration Under the Securities Act or in a Transaction Not Subject to the Registration Requirements of the Securities Act or (2) Pursuant to an Effective Registration Statement Under the Securities Act, in Each Case, in Accordance With All Applicable State Securities Laws and in the Case of a Transaction Exempt From Registration, Unless the Company Has Received an Opinion of Counsel Reasonably Satisfactory to It That Such Transaction Does Not Require Registration Under the Securities Act and Such Other Applicable Laws. Leap Therapeutics, Inc. Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.1
from 8-K 11 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 24 pages [Form of Warrant] Leap Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.5
from S-3 45 pages Leap Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.1
from 8-K 18 pages Leap Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.4
from 10-K 10 pages Amendment No. 2 to Warrant
12/34/56
EX-4.1
from S-4/A 2 pages Form of Common Stock Certificate
12/34/56
EX-4.4
from S-4 11 pages Amendment No. 2 to Warrant
12/34/56
EX-4.3
from S-4 19 pages Registration Rights Agreement
12/34/56
EX-4.2
from S-4 30 pages Amended and Restated Stockholders’ Agreement
12/34/56